BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...

We all know at this point that high-sugar diets are not good for us. They increase our risk of developing cardiovascular ...

ESTHER Rantzen’s daughter has given a heartbreaking health update on her mum’s condition as she lives with terminal lung ...

Lung cancer is one of the most challenging diseases, making early diagnosis crucial for effective treatment. Fortunately, ...

Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...

New research led by American Cancer Society (ACS) researchers estimates more than 3.8 million lung cancer deaths were averted ...

The latest data from Johnson and Johnson's Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso ...

Ochsner Lafayette General Medical Center performed its first procedure with the Ion robotic-assisted bronchoscopy system; ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Dr. Neelu Puri is leading lung cancer research at the University of Illinois College of Medicine Rockford, promoting early ...

New research led by American Cancer Society (ACS) researchers estimates more than 3.8 million lung cancer deaths were averted ...

One half of J&J’s treatment is Lazcluze, a pill that, like Astra’s Tagrisso, blocks a cancer-associated protein called EGFR.